FGF2 and B-cell chronic lymphocytic leukemia: Changes in protein levels could be responsible for these observations; however, a broader case-control study of bFGF polymorphisms and predisposition to B-CLL, as well as an evaluation of bFGF expression levels in larger patient groups, are needed to determine the potential clinical impact of these findings.